Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS · Delayed Price · Currency is USD
0.0350
+0.000835 (2.44%)
At close: Aug 11, 2026
Oncotelic Therapeutics Market Cap
Oncotelic Therapeutics has a market cap or net worth of $15.6 million as of August 11, 2026. Its market cap has decreased by -19.91% in one year.
Market Cap
15.60M
Enterprise Value
28.77M
Revenue
n/a
Ranking
n/a
PE Ratio
0.06
Stock Price
$0.04
ChartMarket Cap Chart
Since April 23, 2019, Oncotelic Therapeutics's market cap has increased from 9.14M to 15.60M, an increase of 70.58%. That is a compound annual growth rate of 7.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 15.98M | -56.97% |
| Dec 31, 2025 | 37.13M | 160.46% |
| Dec 31, 2024 | 14.26M | -6.64% |
| Dec 29, 2023 | 15.27M | -13.24% |
| Dec 30, 2022 | 17.60M | -71.94% |
| Dec 31, 2021 | 62.72M | 225.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| EOM Pharmaceuticals Holdings | 27.83M |
| Provectus Biopharmaceuticals | 23.83M |
| ZIVO Bioscience | 16.69M |
| Finch Therapeutics Group | 16.30M |
| Synlogic | 14.39M |
| Anebulo Pharmaceuticals | 12.41M |
| Zeo ScientifiX | 11.76M |
| Inhibitor Therapeutics | 10.29M |